Core Viewpoint - Jenscare Scientific (Netherlands) B.V., a wholly-owned subsidiary of Jian Shi Technology-B (09877), has received approval for its product LuX-Valve Plus to enter the Hong Kong and Macau medical device market, enabling commercial clinical use in designated medical institutions within the Greater Bay Area [1] Group 1: Product Approval and Market Entry - LuX-Valve Plus has successfully passed the "Hong Kong and Macau Medical Device Pass" approval due to its extensive successful clinical application experience across major regions including Asia-Pacific, North America, Europe, South America, and the Middle East [1] - The product is expected to address the urgent treatment needs of numerous patients suffering from tricuspid regurgitation in the Greater Bay Area [1] Group 2: Strategic Plans and Market Expansion - The company aims to leverage the "Hong Kong and Macau Medical Device Pass" policy opportunity to actively promote the commercialization of LuX-Valve Plus in the Greater Bay Area, accelerating market penetration [1] - This initiative is expected to help the company accumulate critical experience for further expansion into domestic and overseas markets, driving long-term sustainable revenue growth [1]
健世科技-B(09877)：LuX-Valve Plus获准进入港澳药械通